SEC Form 4 · accession 0001209191-18-040447
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin T Conroy
Director
Period of report
Jul 2, 2018
Accepted (ET)
Jul 2, 2018 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001F1 | Jul 2, 2018 | A | 2,878 | $13.55 | A | 2,878 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were issued to the Reporting Person pursuant to his election under the Company's director compensation program in lieu of cash fees of $39,000 for Board services.